NRx Pharmaceuticals Inc. (NRXP)
2.02
-0.25 (-11.01%)
At close: Mar 03, 2025, 3:59 PM
2.05
1.49%
After-hours: Mar 03, 2025, 07:57 PM EST
NRx Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 4.59M | 20.05M | 27.61M | 1.86M | 6.00 | 11.08K | 449.37K |
| Short-Term Investments | n/a | n/a | n/a | 5.97M | 32.01M | 70.77M | 69.03M |
| Long-Term Investments | n/a | n/a | n/a | n/a | 32.01M | 70.77M | 69.03M |
| Other Long-Term Assets | 431K | 21K | 15K | 11K | 1.00 | n/a | n/a |
| Receivables | 6K | n/a | n/a | 831K | n/a | n/a | n/a |
| Inventory | n/a | -7K | n/a | 214K | n/a | n/a | n/a |
| Other Current Assets | 2.28M | 11.48M | 5.11M | 240K | 69.48K | 19.11K | 87K |
| Total Current Assets | 6.88M | 25.8M | 32.71M | 2.93M | 69.49K | 30.19K | 536.38K |
| Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 431K | 21K | 15K | 11K | 32.01M | 70.77M | 69.03M |
| Total Assets | 7.32M | 25.82M | 32.73M | 2.94M | 32.07M | 70.8M | 69.57M |
| Account Payables | 4.63M | 2.08M | 3.69M | 3.15M | 622.44K | 551.1K | 85.67K |
| Deferred Revenue | n/a | n/a | 2.84M | n/a | n/a | n/a | n/a |
| Short-Term Debt | 9.16M | 7.7M | 518K | 249K | n/a | n/a | n/a |
| Other Current Liabilities | 5.25M | 5.81M | 7.72M | 42.71M | -69.48K | n/a | 7.5K |
| Total Current Liabilities | 19.05M | 16.59M | 11.92M | 46.16M | 622.44K | 567.41K | 93.17K |
| Long-Term Debt | n/a | 2.82M | n/a | 548K | 1.95M | 690K | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | n/a | 1.82M | n/a | 548K | 1.95M | 690K | n/a |
| Total Liabilities | 19.05M | 18.41M | 11.92M | 46.71M | 2.57M | 1.26M | 93.17K |
| Total Debt | 9.16M | 10.53M | 518K | 797K | 1.95M | 690K | n/a |
| Common Stock | 84K | 67K | 59K | 43K | 24.5M | 64.54M | 64.48M |
| Retained Earnings | -253.15M | -223.06M | -183.24M | -90.18M | 369.5K | -38.93K | -105.03K |
| Comprehensive Income | -3K | n/a | n/a | n/a | -24.5M | n/a | n/a |
| Shareholders Equity | -11.73M | 7.41M | 20.81M | -43.77M | 29.5M | 69.54M | 69.47M |
| Total Investments | n/a | n/a | n/a | 5.97M | 32.01M | 70.77M | 69.03M |